InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Flesher Gregory J., 董事长兼首席执行官. Officer active across 1 company, notably Reneo Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €54k. History available since 25 August 2021. The latest transaction was filed on 10 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Flesher Gregory J. is the President and CEO of Reneo Pharmaceuticals, Inc. He leads the company with a focus on developing innovative treatments for metabolic diseases. His leadership and strategic vision are essential in guiding Reneo's research and development efforts aimed at improving patients' quality of life.